Two Sigma Securities, LLC In Med Pharmaceuticals Inc. Transaction History
Two Sigma Securities, LLC
- $10.3 Billion
- Q1 2024
A detailed history of Two Sigma Securities, LLC transactions in In Med Pharmaceuticals Inc. stock. As of the latest transaction made, Two Sigma Securities, LLC holds 15,423 shares of INM stock, worth $4,009. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,423
Previous 12,894
19.61%
Holding current value
$4,009
Previous $5,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding INM
# of Institutions
19Shares Held
686KCall Options Held
0Put Options Held
0-
Sabby Management, LLC Upper Saddle River, NJ362KShares$94,0494.44% of portfolio
-
Armistice Capital, LLC New York, NY267KShares$69,4110.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny28.3KShares$7,3580.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il12.7KShares$3,3080.0% of portfolio
-
Qube Research & Technologies LTD London, X0200Shares$520.0% of portfolio
About InMed Pharmaceuticals Inc.
- Ticker INM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 908,761
- Market Cap $236K
- Description
- InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in precl...